Application of Benchtop-magnetic resonance imaging in a nude mouse tumor model

Journal of Experimental and Clinical Cancer Research

Volumn 30, Issue 1, 2011, Pages

  Caysa, Henrike ^a   Metz, Hendrik ^a   Mäder, Karsten ^a   Mueller, Thomas ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GADOBENIC ACID; CONTRAST MEDIUM; DIAGNOSTIC AGENT; DRUG DERIVATIVE; GADOLINIUM; MEGLUMINE; ORGANOMETALLIC COMPOUND; RADIOPHARMACEUTICAL AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BENCHTOP MAGNETIC RESONANCE IMAGING; COLON CARCINOMA; GERM CELL TUMOR; HUMAN; IMAGE QUALITY; IN VIVO STUDY; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TESTIS TUMOR; TUMOR GROWTH; XENOGRAFT; ANIMAL; COLORECTAL TUMOR; DRUG SCREENING; INSTRUMENTATION; MALE; METHODOLOGY; NEOPLASM; NUDE MOUSE; PATHOLOGY; SCINTISCANNING; TUMOR CELL LINE; TUMOR VOLUME;

ANIMALS; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; CONTRAST MEDIA; GADOLINIUM; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MEGLUMINE; MICE; MICE, NUDE; NEOPLASMS, GERM CELL AND EMBRYONAL; ORGANOMETALLIC COMPOUNDS; RADIOPHARMACEUTICALS; TUMOR BURDEN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 79960556946     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-30-69     Document Type: Article

References (21)

1. Benchtop-magnetic resonance imaging (BT-MRI) characterization of push-pull osmotic controlled release systems. Malaterre V, Metz H, Ogorka J, Gurny R, Loggia N, Mader K, J Control Release 2009 133 31 36 10.1016/j.jconrel.2008.09.007 18840483
2. Benchtop-NMR and MRI-a new analytical tool in drug delivery research. Metz H, Mader K, Int J Pharm 2008 364 170 175 10.1016/j.ijpharm.2008.09.033 18930126
3. New insights on poly(vinyl acetate)-based coated floating tablets: characterisation of hydration and CO2 generation by benchtop MRI and its relation to drug release and floating strength. Strubing S, Abboud T, Contri RV, Metz H, Mader K, Eur J Pharm Biopharm 2008 69 708 717 10.1016/j.ejpb.2007.12. 009 18249530
4. Characterization of poly(vinyl acetate) based floating matrix tablets. Strubing S, Metz H, Mader K, J Control Release 2008 126 149 155 10.1016/j.jconrel.2007.11.013 18180069
5. Characterization of scaffolds for tissue engineering by benchtop-magnetic resonance imaging. Nitzsche H, Metz H, Lochmann A, Bernstein A, Hause G, Groth T, Mader K, Tissue Eng Part C Methods 2009 15 513 521 10.1089/ten.tec.2008.0488 19191523
6. Visualizing implanted tumors in mice with magnetic resonance imaging using magnetotactic bacteria. Benoit MR, Mayer D, Barak Y, Chen IY, Hu W, Cheng Z, Wang SX, Spielman DM, Gambhir SS, Matin A, Clin Cancer Res 2009 15 5170 5177 10.1158/1078-0432.CCR-08-3206 19671860
7. Magnetic resonance imaging determination of tumor grade and early response to temozolomide in a genetically engineered mouse model of glioma. McConville P, Hambardzumyan D, Moody JB, Leopold WR, Kreger AR, Woolliscroft MJ, Rehemtulla A, Ross BD, Holland EC, Clin Cancer Res 2007 13 2897 2904 10.1158/1078-0432.CCR-06-3058 17504989 (Pubitemid 46849564)
8. Current issues and perspectives in small rodent magnetic resonance imaging using clinical MRI scanners. Brockmann MA, Kemmling A, Groden C, Methods 2007 43 79 87 10.1016/j.ymeth.2007.07.001 17720566 (Pubitemid 47285734)
9. Imaging living mice using a 1-T compact MRI system. Inoue Y, Nomura Y, Haishi T, Yoshikawa K, Seki T, Tsukiyama-Kohara K, Kai C, Okubo T, Ohtomo K, J Magn Reson Imaging 2006 24 901 907 10.1002/jmri.20713 16969790 (Pubitemid 44549985)
10. Development of a compact mouse MRI using a yokeless permanent magnet. Shirai T, Haishi T, Utsuzawa S, Matsuda Y, Kose K, Magn Reson Med Sci 2005 4 137 143 10.2463/mrms.4.137 16462134
11. Non-invasive in vivo evaluation of in situ forming PLGA implants by benchtop magnetic resonance imaging (BT-MRI) and EPR spectroscopy. Kempe S, Metz H, Pereira PG, Mader K, Eur J Pharm Biopharm 2009
12. Patterns of peripheral enhancement in breast masses: correlation of findings on contrast medium enhanced MRI with histologic features and tumor angiogenesis. Buadu LD, Murakami J, Murayama S, Hashiguchi N, Sakai S, Toyoshima S, Masuda K, Kuroki S, Ohno S, J Comput Assist Tomogr 1997 21 421 430 10.1097/00004728-199705000-00016 9135652 (Pubitemid 27212422)
13. Chondroblastic osteosarcoma: characterisation by gadolinium-enhanced MR imaging correlated with histopathology. Geirnaerdt MJ, Bloem JL, van der Woude HJ, Taminiau AH, Nooy MA, Hogendoorn PC, Skeletal Radiol 1998 27 145 153 10.1007/s002560050354 9554005 (Pubitemid 28181759)
14. MRI of breast tumors. Kuhl CK, Eur Radiol 2000 10 46 58 10.1007/s003300050006 10663717 (Pubitemid 30141129)
15. Benign and malignant musculoskeletal masses: MR imaging differentiation with rim-to-center differential enhancement ratios. Ma LD, Frassica FJ, McCarthy EF, Bluemke DA, Zerhouni EA, Radiology 1997 202 739 744 9051028 (Pubitemid 27093449)
16. Hepatic metastases and cavernous hemangiomas: distinction with standard- and triple-dose gadoteridol-enhanced MR imaging. Mitchell DG, Saini S, Weinreb J, De Lange EE, Runge VM, Kuhlman JE, Parisky Y, Johnson CD, Brown JJ, Schnall M, et al. Radiology 1994 193 49 57 8090921 (Pubitemid 24297998)
17. Peripheral enhancement and spatial contrast uptake heterogeneity of primary breast tumors: quantitative assessment with dynamic MRI. Mussurakis S, Gibbs P, Horsman A, J Comput Assist Tomogr 1998 22 35 46 10.1097/00004728- 199801000-00007 9448759 (Pubitemid 28087317)
18. Evaluating changes in tumor volume using magnetic resonance imaging during the course of radiotherapy treatment of high-grade gliomas: Implications for conformal dose-escalation studies. Tsien C, Gomez-Hassan D, Ten Haken RK, Tatro D, Junck L, Chenevert TL, Lawrence T, Int J Radiat Oncol Biol Phys 2005 62 328 332 10.1016/j.ijrobp.2004.10.010 15890571 (Pubitemid 40704446)
19. Breast cancer imaging with MRI. Morris EA, Radiol Clin North Am 2002 40 443 466 10.1016/S0033-8389(01)00005-7 12117186 (Pubitemid 34765033)
20. Correlation of dynamic contrast-enhanced MR imaging with histologic tumor grade: comparison of macromolecular and small-molecular contrast media. Daldrup H, Shames DM, Wendland M, Okuhata Y, Link TM, Rosenau W, Lu Y, Brasch RC, AJR Am J Roentgenol 1998 171 941 949 9762973 (Pubitemid 28449949)
21. Breast lesions: correlation of contrast medium enhancement patterns on MR images with histopathologic findings and tumor angiogenesis. Buadu LD, Murakami J, Murayama S, Hashiguchi N, Sakai S, Masuda K, Toyoshima S, Kuroki S, Ohno S, Radiology 1996 200 639 649 8756909 (Pubitemid 26282258)